Explore more publications!
Tech Daily Utah
Got News to Share?

Tech Daily Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Daily Utah.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on December 17, 2025

Techcyte awarded patent, strengthening its AI training framework and accelerating development of digital diagnostics
Dec. 17, 2025

Techcyte awarded patent, strengthening its AI training framework and accelerating development of digital diagnostics

Indeterminate EIN Presswire
Lumea Announces Collaboration with Cleveland Diagnostics to Enable Greater Access to IsoPSA® Testing
Dec. 17, 2025

Lumea Announces Collaboration with Cleveland Diagnostics to Enable Greater Access to IsoPSA® Testing

Indeterminate EIN Presswire
AlphaTON Capital Corp Issues Clarification on Anduril Industries Investment Program
Dec. 17, 2025

AlphaTON Capital Corp Issues Clarification on Anduril Industries Investment Program

Indeterminate GlobeNewswire
Sapu BioScience Highlights TGFB2-Guided Strategy to Enhance Taxane Therapies, Reinforcing the Rationale for Sapu-001
Dec. 17, 2025

Sapu BioScience Highlights TGFB2-Guided Strategy to Enhance Taxane Therapies, Reinforcing the Rationale for Sapu-001

Indeterminate GlobeNewswire
Guardforce AI Announces Receipt of Nasdaq Minimum Bid Price Deficiency Notification Letter
Dec. 17, 2025

Guardforce AI Announces Receipt of Nasdaq Minimum Bid Price Deficiency Notification Letter

Indeterminate GlobeNewswire
Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders
Dec. 17, 2025

Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders

Indeterminate GlobeNewswire
CISO Global Books Over $1.1M in CHECKLIGHT® Software Sales - 
Dec. 17, 2025

CISO Global Books Over $1.1M in CHECKLIGHT® Software Sales - 

Indeterminate GlobeNewswire
Boumarang, Inc. Files S-1 Registration Statement with the U.S. Securities and Exchange Commission
Dec. 17, 2025

Boumarang, Inc. Files S-1 Registration Statement with the U.S. Securities and Exchange Commission

Indeterminate GlobeNewswire
Voting Rights and Shares Capital of the Company
Dec. 17, 2025

Voting Rights and Shares Capital of the Company

Indeterminate GlobeNewswire
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Dec. 17, 2025

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Indeterminate GlobeNewswire
CancerVax Reports Nanoparticle Component Success in Preparation for Animal Studies
Dec. 17, 2025

CancerVax Reports Nanoparticle Component Success in Preparation for Animal Studies

Indeterminate GlobeNewswire
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
Dec. 17, 2025

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings

Indeterminate GlobeNewswire
Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Dec. 17, 2025

Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

Indeterminate GlobeNewswire
Immuneering Advances Towards Dosing First Patient in Phase 3 Atebimetinib Trial for First-Line Metastatic Pancreatic Cancer Patients, Securing Alignment with FDA and EMA
Dec. 17, 2025

Immuneering Advances Towards Dosing First Patient in Phase 3 Atebimetinib Trial for First-Line Metastatic Pancreatic Cancer Patients, Securing Alignment with FDA and EMA

Indeterminate GlobeNewswire
Kalaris Therapeutics Reports Positive Initial Phase 1a Data for TH103 in Treatment-Naïve Neovascular AMD
Dec. 17, 2025

Kalaris Therapeutics Reports Positive Initial Phase 1a Data for TH103 in Treatment-Naïve Neovascular AMD

Indeterminate GlobeNewswire
Inventiva présentera à la 44e conférence annuelle J.P. Morgan Healthcare  
Dec. 17, 2025

Inventiva présentera à la 44e conférence annuelle J.P. Morgan Healthcare  

Indeterminate GlobeNewswire
Inventiva to Present at the 44th Annual J.P. Morgan Healthcare Conference
Dec. 17, 2025

Inventiva to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
SSRG Acquires Pillar Security, Expanding Ontario Footprint
Dec. 17, 2025

SSRG Acquires Pillar Security, Expanding Ontario Footprint

Indeterminate GlobeNewswire
iDox.ai Announces Privacy Scout Family Edition to Strengthen AI Safety for Children at Home
Dec. 17, 2025

iDox.ai Announces Privacy Scout Family Edition to Strengthen AI Safety for Children at Home

Indeterminate GlobeNewswire
Canadian Safety Achievement Awards Honour AlumaSafway with 14 National Safety Awards
Dec. 17, 2025

Canadian Safety Achievement Awards Honour AlumaSafway with 14 National Safety Awards

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions